Tendon and Ligament Regeneration Pathways In rodent models of tendon injury, BPC-157 demonstrated increased fibroblast activity and collagen organization
Transient zinc increases may arise from various mechanisms, including efflux from vesicles known as zincosomes, 30 or changes in cellular redox potential facilitated by cytosolic proteins
Ascletis reported enhanced fat loss with ASC47 in semaglutide combo studies
Copper changes the compounds color, coordination chemistry, mass interpretation, and potentially its behavior in experimental systems
Semaglutide also reduced skeletal muscle mass
Most common side effects (12mg dose, across TRIUMPH-4 and TRIUMPH-1): Nausea: 43% TRIUMPH-4 / ~38% TRIUMPH-1 (mostly during dose escalation) Diarrhea: 33% / ~28% (peaks weeks 48, improves by week 16) Dysesthesia: 20.9% (tingling sensations onset variable, long-term persistence unknown) Vomiting: 21% / ~25% (decreases after month 3) Constipation: 25% Discontinuation rates: 18.2% in TRIUMPH-4 (osteoarthritis population), 11.3% in TRIUMPH-1 (general obesity population)